{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:03:22Z","timestamp":1782443002855,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.4158\/ep-2020-0035","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T14:19:25Z","timestamp":1601475565000},"page":"1026-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Christopher A.","family":"Muir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Weissberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Samaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2020-0035_bb0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med."},{"key":"10.4158\/EP-2020-0035_bb0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/jcem-71-3-661","article-title":"Antithyroid peroxidase autoantibodies in thyroid diseases","volume":"71","author":"Mariotti","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0035_bb0020","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jcem.87.7.8678","article-title":"Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies","volume":"87","author":"Huber","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0035_bb0025","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP-2020-0035_bb0030","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/thy.2019.0085","article-title":"The long-term outcome of treatment for Graves\u2019 hyperthyroidism","volume":"29","author":"Sj\u00f6lin","year":"2019","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-13-0811","article-title":"Long-term prognosis after medical treatment of Graves\u2019 disease in a northern Swedish population 2000\u20132010","volume":"170","author":"Mohlin","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP-2020-0035_bb0040","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis","volume":"98","author":"Sundaresh","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0035_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/thy.2016.0343","article-title":"Comparative effectiveness of treatment choices for Graves\u2019 hyperthyroidism: a historical cohort study","volume":"27","author":"Sundaresh","year":"2017","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0050","first-page":"307","article-title":"Remission of Graves\u2019 hyperthyroidism treated with methimazole","volume":"54","author":"Bola\u00f1os","year":"2002","journal-title":"Rev Invest Clin."},{"key":"10.4158\/EP-2020-0035_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1440475","article-title":"Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves\u2019 hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study","volume":"144","author":"Glinoer","year":"2001","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP-2020-0035_bb0060","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40618-018-0918-9","article-title":"Antithyroid drug treatment for Graves\u2019 disease: baseline predictive models of relapse after treatment for a patient-tailored management","volume":"41","author":"Masiello","year":"2018","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP-2020-0035_bb0065","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2005.15.1047","article-title":"Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves\u2019 disease","volume":"15","author":"Quadbeck","year":"2005","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves\u2019 disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.2000.10.891","article-title":"Remission of Graves\u2019 hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment","volume":"10","author":"Takasu","year":"2000","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12020-013-9895-0","article-title":"Predictors of long-term remission in patients with Graves\u2019 disease: a single center experience","volume":"44","author":"Anagnostis","year":"2013","journal-title":"Endocrine."},{"key":"10.4158\/EP-2020-0035_bb0085","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased remission rates after long-term methimazole therapy in patients with Graves\u2019 disease: results of a randomized clinical trial","volume":"29","author":"Azizi","year":"2019","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/EJE-16-0725","article-title":"Can we predict relapse in Graves\u2019 disease? Results from a systematic review and meta-analysis","volume":"176","author":"Struja","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP-2020-0035_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/ct.2017;29.5-7","article-title":"Does meta-analysis prove which factors predict relapse after antithyroid drugs are discontinued?","volume":"29","author":"Spaulding","year":"2017","journal-title":"Clin Thyroidol."},{"key":"10.4158\/EP-2020-0035_bb0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(62)90628-1","article-title":"The prognostic significance of thyroid antibodies in the management of thyrotoxicosis","volume":"2","author":"Irvine","year":"1962","journal-title":"Lancet."},{"key":"10.4158\/EP-2020-0035_bb0105","first-page":"328","article-title":"Retrospective revaluation of the significance of thyroid microsomal antibody in the treatment of Graves\u2019 disease","volume":"114","author":"Hamada","year":"1987","journal-title":"Acta Endocrinol (Copenh)."},{"key":"10.4158\/EP-2020-0035_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-57-3-563","article-title":"Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves\u2019 hyperthyroidism","volume":"57","author":"Romaldini","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP-2020-0035_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2007-957347","article-title":"Improved prediction of relapse of Graves\u2019 thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies","volume":"39","author":"Schott","year":"2007","journal-title":"Horm Metab Res."},{"key":"10.4158\/EP-2020-0035_bb0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/thy.2006.16.1041","article-title":"Differential evolution of thyroid peroxidase and thyrotropin receptor antibodies in Graves\u2019 disease: thyroid peroxidase antibody activity reverts to pretreatment level after carbimazole withdrawal","volume":"16","author":"Guilhem","year":"2006","journal-title":"Thyroid."},{"key":"10.4158\/EP-2020-0035_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08916930008994089","article-title":"Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease","volume":"32","author":"Lavard","year":"2000","journal-title":"Autoimmunity."},{"key":"10.4158\/EP-2020-0035_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3803\/EnM.2019.34.3.268","article-title":"Changes in thyroid peroxidase and thyroglobulin antibodies might be associated with Graves\u2019 disease relapse after antithyroid drug therapy","volume":"34","author":"Choi","year":"2019","journal-title":"Endocrinol Metab (Seoul)."},{"key":"10.4158\/EP-2020-0035_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00251-002-0453-9","article-title":"The human anti-thyroid peroxidase autoantibody repertoire in Graves\u2019 and Hashimoto\u2019s autoimmune thyroid diseases","volume":"54","author":"Chard\u00e8s","year":"2002","journal-title":"Immunogenetics."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20482321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:36Z","timestamp":1761516576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20482321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1530891X20482321"],"URL":"https:\/\/doi.org\/10.4158\/ep-2020-0035","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2020-0035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}